Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The development of cellular therapeutics is acutely dependent on the ability to evaluate the functional characteristics of the cells in predictive animal models. This forms the basis of key pre-clinical data packages that are key for regulatory submissions preceding human clinical trials. The development of appropriate model systems, the execution of the surgical techniques to deliver cells to the target tissue, and the techniques to functionally analyze these cells in situ are technically challenging. Michael Laflamme’s laboratory is focussed on the development of protocols for making and testing human stem cell derived cardiomyocytes in animal models and is the world leader in this field. BlueRock Therapeutics (BRT) is actively developing a clinical and commercial pipeline of cell therapies for cardiac indications. This proposal bridges development work being done in the Laflamme lab and at BRT. The data that will be generated in the project will be instrumental in shaping BRT’s development pipeline. Further, the project will provide Wahiba, the proposed trainee, with an opportunity to work with BRT staff to propose a business case and implementation plan for the internalization of this highly specialized skill set within the company.
Michael Alan Laflamme
Wahiba Dhahri
BlueRock Therapeutics ULC
Other
Other
University of Toronto
Elevate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.